Position in HROW
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$55,076,120
-$35,235,339 QoQ
Shares Held
1,562,000
-15.3% QoQ
Ownership
4.19%
of shares outstanding
% of Portfolio
6.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 30.608450704225355.ToString("F0")%
Shared 69.39154929577465.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Derivatives in HROW
reported options exposure · as of Mar 31, 2026CallValue
$1,445,660
CallShares
41,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Private Capital Management, LLC holds $82,203,417 across 2 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (67.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
This page
|
1,562,000 | $55,076,120 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
357,644 | $27,127,297 |
All Filings in HROW
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,076,120 | 1,562,000 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,445,660 | 41,000 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $2,033,500 | 41,500 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $90,311,459 | 1,843,091 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,084,050 | 22,500 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $89,405,891 | 1,855,664 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $59,411,324 | 1,945,361 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $1,633,890 | 53,500 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,157,100 | 43,500 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $50,290,678 | 1,890,627 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $56,866,679 | 1,694,983 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $97,279,097 | 2,163,681 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $56,713,237 | 2,714,851 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,853,959 | 3,012,393 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,298,366 | 2,794,497 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $20,360,853 | 1,416,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,940,667 | 1,152,346 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $24,666,656 | 1,165,721 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,374,916 | 1,041,661 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,424,326 | 1,029,356 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,253,435 | 996,351 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||